Disease modifying mechanism of action: short treatment course results in significant and durable clinical response in psoriasis patients si-544 ...

Jenifer Soung, MD, fo Southern California Dermatology, discussed how glucagon-like peptide-1 receptor agonists aid in treating patients with psoriatic disease. Captions are auto-generated.

Discover tips on navigating psoriasis treatments with resilience. Learn from a personal journey through six biologics, emphasizing hope and perseverance.

Bristol Myers Squibb Co said on Tuesday its experimental plaque psoriasis oral drug proved more effective in clearing moderate to severe cases of the skin condition than placebo or Amgen Inc's Otezla ...

In March 2025, SFA Therapeutics announced that two head-to-head preclinical studies of its oral psoriasis therapy candidate, ...

Topicals are often the first-line treatment for psoriasis, but as the condition progresses, you may need to consider systemic treatments to manage your symptoms. Here’s what to know about your options ...

The Plaque Psoriasis Pipeline Report provides disease overview, pipeline scenario and therapeutic assessment of the key ...

A recent review explored the benefits of biosimilars for patients with moderate to severe chronic plaque psoriasis.

Researchers at VIB and Ghent University have uncovered a key mechanism that protects the skin from harmful inflammation.